FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
By Stephanie Brown HealthDay Reporter
WEDNESDAY, July 2, 2025 -- The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications, including certain formulations of amphetamine and methylphenidate, to warn about the medication's risk for weight loss and other adverse reactions in patients younger than 6 years of age.
Extended-release stimulants are currently not approved for children younger than 6 years, but health care professionals do prescribe them "off label" to treat ADHD.
Clinical trials have shown that compared with older children, patients younger than 6 years have higher levels of the drug in their bodies and higher rates of side effects. Children younger than 6 years can also suffer clinically significant weight loss.
The FDA is requiring a Limitation of Use section be added to the prescribing information of all extended-release stimulants. This section will include a statement about the higher plasma exposures and higher rates of adverse reactions observed in children younger than 6 years.
For children taking an extended-release stimulant, health care providers should regularly chart the patient's growth and development, be aware that interventions may be needed to address and mitigate any weight loss, and consider prescribing other ADHD medications, such as immediate-release stimulants, or recommend behavioral therapies.
If parents or caregivers observe weight loss in their child who is taking an extended-release stimulant, they should contact their pediatrician or another health care provider to review the benefits and harms of continuing treatment.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
ADHD Drugs Often Prescribed Too Early To Preschoolers
TUESDAY, Sept. 2, 2025 — Expert consensus on the treatment of preschoolers diagnosed with attention deficit hyperactivity disorder (ADHD) is clear: Try behavioral therapies...
HHS, Department of Education Call for Integration of Nutrition Education in Medical Schools
THURSDAY, Aug. 28, 2025 -- The U.S. Department of Health and Human Services and Department of Education announced an initiative Wednesday urging medical schools to integrate...
Fatty Foods Might Contribute To Childhood Asthma
THURSDAY, Aug. 28, 2025 — Fatty foods might contribute to asthma in children, a new study says. Fats found in certain foods are linked to neutrophilic asthma, a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.